The Prevention Effect of Lactobacillus Plantarum 17-5 on Escherichia Coli-Induced Mastitis in Mice
Overview
Authors
Affiliations
Mastitis is the most economically important disease affecting the dairy industry worldwide. Lactobacillus plantarum, an important probiotic with a wide range of applications, has potential anti-inflammatory properties and has become a currently strong candidate for mastitis therapies. In the current study, we evaluated the prevention effect of Lactobacillus plantarum 17-5 on Escherichia coli-induced mastitis in mice. The results showed that pretreatment with L. plantarum 17-5 maintained the integrity of tight junctions; improved inflammatory injury; decreased MPO activity and the mRNA expression levels of IL1β, IL6, and TNFα; and inhibited the NF-κB and MAPK signaling pathways in mice mammary tissue. The results indicated that Lactobacillus plantarum 17-5 had excellent anti-inflammatory activities and could be developed into microecological preparation for clinical use to prevent mastitis.
Bioactive Compounds and Probiotics Mitigate Mastitis by Targeting NF-κB Signaling Pathway.
Khan M, Li L, Wang T, Liu X, Chen W, Ma Q Biomolecules. 2024; 14(8).
PMID: 39199398 PMC: 11352841. DOI: 10.3390/biom14081011.
Izhar M, Nawaz M, Yaqub T, Avais M, Anjum A BMC Microbiol. 2024; 24(1):310.
PMID: 39174931 PMC: 11340152. DOI: 10.1186/s12866-024-03464-5.